{
  "id": "da4fb71fa9979508",
  "title": "Adolore BioTherapeutics Announces FDA Orphan Drug Designation for its Kv7 - activating rdHSV - CA8 * Therapy in the Treatment of Erythromelalgia",
  "description": "20260115T000000Z",
  "content": "",
  "source": "hawaiitelegraph.com",
  "source_url": "http://www.hawaiitelegraph.com/news/278809803/adolore-biotherapeutics-announces-fda-orphan-drug-designation-for-its-kv7-activating-rdhsv-ca8-therapy-in-the-treatment-of-erythromelalgia",
  "published_at": "20260115T000000Z",
  "fetched_at": "2026-01-15T00:21:56.842948+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": "United States",
  "raw_data": {
    "url": "http://www.hawaiitelegraph.com/news/278809803/adolore-biotherapeutics-announces-fda-orphan-drug-designation-for-its-kv7-activating-rdhsv-ca8-therapy-in-the-treatment-of-erythromelalgia",
    "url_mobile": "",
    "title": "Adolore BioTherapeutics Announces FDA Orphan Drug Designation for its Kv7 - activating rdHSV - CA8 * Therapy in the Treatment of Erythromelalgia",
    "seendate": "20260115T000000Z",
    "socialimage": "",
    "domain": "hawaiitelegraph.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}